跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,949 条关于
“RAF-MEK-ERK pathway”
全部
16,949
临床试验
10,366
药物
1,170
机构
99
资讯
5,314
去年
Neurofibromatoses Pipeline Shows Strong Activity with 12+ Therapies in Development Across Multiple Clinical Stages
去年
European Commission Approves First MEK Inhibitor for NF1-Associated Plexiform Neurofibromas in Adults and Children
去年
Servier and Black Diamond Therapeutics Forge $780M Global Licensing Deal for Novel RAF/RAS Cancer Therapy
8个月前
Verastem Discontinues KRAS G12C Trial to Focus on Promising G12D Inhibitor with 69% Response Rate
2年前
Nested Therapeutics' NST-628: A Novel Pan-RAF–MEK Molecular Glue for MAPK Pathway Inhibition
2年前
Pasithea Therapeutics Announces FDA Acceptance of IND Application for PAS-004 in Advanced Cancer Patients
去年
Pasithea's PAS-004 Shows Strong Target Engagement with 91% pERK Inhibition in Phase 1 Cancer Trial
去年
Verastem Oncology to Present New LGSOC Treatment Data at SGO 2025 Annual Meeting
2年前
Pasithea Therapeutics Initiates Phase 1 Trial of PAS-004, a Novel MEK Inhibitor, for Advanced Solid Tumors and NF1
去年
Novel Drug Combination Overcomes Resistance in BRAF-Mutated Melanoma, Prevents Brain Metastasis
第 1 页,共 532 页
上一页
下一页